title: [Surgery of locally advanced non-small-cell bronchial cancer after intensive preoperative chemo-/radiotherapy].
abstract: From March 1991 to June 1993 50 patients with local advanced NSCLC (mediastinoscopy obligatory) have been entered into an ongoing trial with preoperative chemotherapy and simultaneous chemo-/radiotherapy, followed by re-mediastinoscopy and surgery. Clinical response rates after chemotherapy amounted to 66.8% after chemo/radiotherapy 77.5%, no severe toxicity was observed. 36 patients ultimately underwent operation, 29 with a curative, 5 with a palliative resection and 2 with an explorative thoracotomy. Pathological complete remission rates of the primary tumor were found in 11 (32.3%), R0-resection in 18 (52.9%) and R1-resection in 5 (14.7%) cases. Sterilisation rates of mediastinal nodes were found in 86.3% of N2 tumors and 66.6% of N3 tumors. Median survival time ranged between 21 months for stage III a and 16 months for III b disease. This intensive preoperative neoadjuvant treatment is tolerable and effective, the requirements for a randomised comparative trial was met.
authors.affiliation: Abteilung für Thoraxchirurgie und thorakale Endoskopie, Ruhrlandklinik, Essen.
authors.forename: G
authors.initials: G
authors.lastname: Stamatis
authors.forename: H
authors.initials: H
authors.lastname: Wilke
authors.forename: W
authors.initials: W
authors.lastname: Eberhardt
authors.forename: V
authors.initials: V
authors.lastname: Budach
authors.forename: M
authors.initials: M
authors.lastname: Stuschke
authors.forename: N
authors.initials: N
authors.lastname: Konietzko
authors.forename: H
authors.initials: H
authors.lastname: Sack
authors.forename: S
authors.initials: S
authors.lastname: Seeber
authors.forename: D
authors.initials: D
authors.lastname: Greschuchna
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001999:Bronchoscopy; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D008297:Male; D008481:Mediastinoscopy; D008875:Middle Aged; D009367:Neoplasm Staging; D010865:Pilot Projects; D011446:Prospective Studies; D011882:Radiotherapy, High-Energy; D012086:Reoperation
chemical_list: D005047:Etoposide; D002945:Cisplatin
vernacular_title: Chirurgie des lokal fortgeschrittenen nicht-kleinzelligen Bronchialcarcinoms nach intensiver präoperativer Chemo-/Strahlentherapie.